img

Global Computational Biology Industry Outlook 2024: Overview, Opportunities, Key Companies and Forecast to 2034


Published on: 2024-01-04 | No of Pages : 411 | Industry : Service & Software

Publisher : GRD Survey | Format : PDF

Global Computational Biology Industry Outlook 2024: Overview, Opportunities, Key Companies and Forecast to 2034

Executive Summary

According to GRD Survey data, the global Computational Biology market is estimated at 2420 million US$ in 2021 and is expected to 5660 million US$ by the end of 2028, growing at a CAGR of 12.9% in the forecast period from 2022 to 2028.

This report studies the Computational Biology market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (Million USD) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with revenue, market share and growth Rate of Computational Biology in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
In-House
Contract

Market Snapshot, By Application
Cellular & Biological Simulation
Pharmacogenomics
Drug Discovery
Drug Development
Lead Optimization
Lead Discovery
Pharmacokinetics
Disease Modeling
Clinical Trials

Main Market Players Analyzed in this report, including
Simulation Plus
Schrodinger
Rhenovia Pharma
Nimbus Discovery
Leadscope
Insilico Biotechnology
Genedata
Entelos
Compugen
Chemical Computing
Certara
Accelrys

The study objectives of this report are
To study and analyze the global Computational Biology market size (Million USD) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Computational Biology market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Computational Biology manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Computational Biology market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Computational Biology submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Computational Biology are as follows
History Year2016-2020
Base Year2020
Estimated Year2021
Forecast Year 2021 to 2027

This report includes the estimation of market size from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Content

Global Computational Biology Industry Outlook 2022: Overview, Opportunities, Key Companies and Forecast to 2028.pdf

List of Figure

Table of Contents

1 Market Definition & Scope
1.1 Definition & Scope
1.2 Computational Biology Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Computational Biology Market Performance and Outlook

2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter’s Five Forces Analysis
2.3 Comparison of Alternatives and Computational Biology

3 3 Industrial Lift Cycle and Main Buyers Analysis
3.1 Industry Life Cycle Analysis
3.2 Key Buying Industries/Consumers
3.2.1 Major Buyers in Cellular & Biological Simulation
3.2.2 Major Buyers in Pharmacogenomics

4 Market Segment: by Type
4.1 Computational Biology Type Introduction
4.1.1 In-House
4.1.2 Contract
4.2 Global Computational Biology Revenue by Type 2016-2021

5 Market Segment: by Application
5.1 Computational Biology Type Introduction
5.1.1 Cellular & Biological Simulation
5.1.2 Pharmacogenomics
5.1.3 Drug Discovery
5.1.3 Drug Development
5.1.4 Lead Optimization
5.1.5 Lead Discovery
5.1.6 Pharmacokinetics
5.1.7 Disease Modeling
5.1.8 Clinical Trials
5.2 Global Computational Biology Revenue by Application 2016-2021

6 Marke Segment: by Region
6.1 Global Computational Biology Market by Region
6.2 North America Computational Biology Market 2016-2021
6.3 Europe Computational Biology Market 2016-2021
6.4 Asia Pacific Computational Biology Market 2016-2021
6.5 South America Computational Biology Market 2016-2021
6.6 Middle East and Africa Computational Biology Market 2016-2021

7 North America
7.1 North America Computational Biology Market by Country 2016-2021
7.2 United States
7.3 Canada
7.4 Mexico

8 Europe
8.1 Europe Computational Biology Market by Country 2016-2021
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain

9 Asia Pacific
9.1 Asia Pacific Computational Biology Market by Country 2016-2021
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia

10 South America
10.1 South America Computational Biology Market by Country 2016-2021
10.2 Brazil
10.3 Argentina
10.4 Colombia

11 Middle East and Africa
11.1 Middle East and Africa Computational Biology Market by Country 2016-2021
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa

12 Key Participants Company Information
12.1 Simulation Plus
12.1.1 Simulation Plus Company Information
12.1.2 Simulation Plus Computational Biology Product Portfolio, Specification and Application
12.1.3 Simulation Plus Computational Biology Revenue and Gross Margin (2019-2021)
12.1.4 Simulation Plus Key Development
12.2 Schrodinger
12.2.1 Schrodinger Company Information
12.2.2 Schrodinger Computational Biology Product Portfolio, Specification and Application
12.2.3 Schrodinger Computational Biology Revenue and Gross Margin (2019-2021)
12.2.4 Schrodinger Key Development
12.3 Rhenovia Pharma
12.3.1 Rhenovia Pharma Company Information
12.3.2 Rhenovia Pharma Computational Biology Product Portfolio, Specification and Application
12.3.3 Rhenovia Pharma Computational Biology Revenue and Gross Margin (2019-2021)
12.3.4 Rhenovia Pharma Key Development
12.4 Nimbus Discovery
12.4.1 Nimbus Discovery Company Information
12.4.2 Nimbus Discovery Computational Biology Product Portfolio, Specification and Application
12.4.3 Nimbus Discovery Computational Biology Revenue and Gross Margin (2019-2021)
12.4.4 Nimbus Discovery Key Development
12.5 Leadscope
12.5.1 Leadscope Company Information
12.5.2 Leadscope Computational Biology Product Portfolio, Specification and Application
12.5.3 Leadscope Computational Biology Revenue and Gross Margin (2019-2021)
12.5.4 Leadscope Key Development
12.6 Insilico Biotechnology
12.6.1 Insilico Biotechnology Company Information
12.6.2 Insilico Biotechnology Computational Biology Product Portfolio, Specification and Application
12.6.3 Insilico Biotechnology Computational Biology Revenue and Gross Margin (2019-2021)
12.6.4 Insilico Biotechnology Key Development
12.7 Genedata
12.7.1 Genedata Company Information
12.7.2 Genedata Computational Biology Product Portfolio, Specification and Application
12.7.3 Genedata Computational Biology Revenue and Gross Margin (2019-2021)
12.7.4 Insilico Biotechnology Key Development
12.9 Compugen
12.9.1 Compugen Company Information
12.9.2 Compugen Computational Biology Product Portfolio, Specification and Application
12.9.3 Compugen Computational Biology Revenue and Gross Margin (2019-2021)
12.9.4 Compugen Key Development
12.8 Entelos
12.8.1 Entelos Company Information
12.8.2 Entelos Computational Biology Product Portfolio, Specification and Application
12.8.3 Entelos Computational Biology Revenue and Gross Margin (2019-2021)
12.8.4 Entelos Key Development
12.11 Certara
12.11.1 Certara Company Information
12.11.2 Certara Computational Biology Product Portfolio, Specification and Application
12.11.3 Certara Computational Biology Revenue and Gross Margin (2019-2021)
12.11.4 Certara Key Development
12.12 Accelrys
12.12.1 Accelrys Company Information
12.12.2 Accelrys Computational Biology Product Portfolio, Specification and Application
12.12.3 Accelrys Computational Biology Revenue and Gross Margin (2019-2021)
12.12.4 Accelrys Key Development

13 Global Computational Biology Market Forecast by Region by Type and by Application
13.1 Global Computational Biology Revenue Forecast 2022-2027
13.2 Global Computational Biology Forecast by Regions
13.3 Global Computational Biology Forecast by Type
13.4 Global Computational Biology Forecast by Application

14 Analyst Views and Conclusions

15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer